Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine

NCT06821100 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Vaccine Response
COVID-19 Vaccine
Immune Response to Covid 19 Vaccination

Interventions

DRUG: Thymalfasin (Thymosin alpha 1, Ta1)

Sponsor

The Methodist Hospital Research Institute